Icelandic Salmon (ISLAX) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
10 Feb, 2026Executive summary
Reported a challenging quarter with an operational loss of EUR -9.4 million, driven by high production costs and extraordinary items, including a EUR -3.2 million biomass value adjustment.
Achieved nearly 100% utilization of maximum allowed biomass at key sites and all-time high smolt output for 2025, supporting future production.
Harvested 3,800 tonnes in the quarter, up from 1,800 tonnes in the same quarter last year.
Positive developments in harvesting costs, price achievement, and fish size compared to the market, with strong price realization in North America and Asia.
Financial highlights
Operating income rose to EUR 25.1 million in Q3 2025 from EUR 14.3 million in Q3 2024; YTD 2025 operating income at EUR 60.6 million.
EBIT for the quarter was EUR -9.4 million, impacted by high production costs and a one-time biomass value adjustment.
Net interest-bearing debt, including leasing, ended at EUR 123 million, up EUR 9.7 million from the previous quarter.
Available liquidity at quarter-end was EUR 52 million.
Equity ratio decreased from 47% to 44% during the quarter.
Outlook and guidance
Volume guidance for 2025 is 13,000 tonnes, with a significant increase to 21,000 tonnes in 2026.
Expecting cost reductions in Q4 2025 and into 2026 due to higher volumes, improved biology, and generational shift.
Anticipate a stronger market in 2026, with normalized prices and improved price achievement.
Contract share expected to remain low at 1% for Q4 and 2% for the full year.
Latest events from Icelandic Salmon
- Q4 2025 delivered improved profitability and sets up a 67% volume growth for 2026.ISLAX
Q4 202510 Feb 2026 - Biological setbacks drove Q2 and H1 losses, but new licenses and ASC certification support growth.ISLAX
Q2 202423 Jan 2026 - Harvest and EBIT were low in Q3, but strong demand and higher volumes are expected in Q4.ISLAX
Q3 202414 Jan 2026 - Stabilized Q4 operations, strong demand, and 2025 guidance at 15,000 tonnes maintained.ISLAX
Q4 202417 Dec 2025 - Biological setbacks and weak prices drove a Q1 2025 loss, but 2025 guidance is unchanged.ISLAX
Q1 202525 Nov 2025 - Operational losses and lower guidance amid biological, regulatory, and market challenges.ISLAX
Q2 202523 Nov 2025